Clinical Trial Update: Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants

View source ↗

Summary

Ongoing clinical trial updating brain amyloid and glucose metabolism profiles in ALFA project participants to deepen understanding of Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | Conditions: Alzheimer's Disease | Status: RECRUITING